These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 33151293)

  • 1. Rapid Progression of Kidney Dysfunction in People Living With HIV: Use of Polygenic and Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Risk Scores.
    Dietrich LG; Thorball CW; Ryom L; Burkhalter F; Hasse B; Thurnheer MC; Weisser M; Schmid P; Bernasconi E; Darling KEA; Buvelot H; Fellay J; Ledergerber B; Tarr PE;
    J Infect Dis; 2021 Jun; 223(12):2145-2153. PubMed ID: 33151293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of Genetic Background and Data Collection on Adverse Events of Anti-human Immunodeficiency Virus (HIV) Drugs (D:A:D) Clinical Risk Score to Chronic Kidney Disease in Swiss HIV-infected Persons With Normal Baseline Estimated Glomerular Filtration Rate.
    Dietrich LG; Barceló C; Thorball CW; Ryom L; Burkhalter F; Hasse B; Furrer H; Weisser M; Steffen A; Bernasconi E; Cavassini M; de Seigneux S; Csajka C; Fellay J; Ledergerber B; Tarr PE
    Clin Infect Dis; 2020 Feb; 70(5):890-897. PubMed ID: 30953057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary Artery Disease-Associated and Longevity-Associated Polygenic Risk Scores for Prediction of Coronary Artery Disease Events in Persons Living With Human Immunodeficiency Virus: The Swiss HIV Cohort Study.
    Schoepf IC; Thorball CW; Ledergerber B; Engel T; Raffenberg M; Kootstra NA; Reiss P; Hasse B; Marzolini C; Thurnheer C; Seneghini M; Bernasconi E; Cavassini M; Buvelot H; Kouyos R; Günthard HF; Fellay J; Tarr PE;
    Clin Infect Dis; 2021 Nov; 73(9):1597-1604. PubMed ID: 34091660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher Prevalence and Faster Progression of Chronic Kidney Disease in Human Immunodeficiency Virus-Infected Middle-Aged Individuals Compared With Human Immunodeficiency Virus-Uninfected Controls.
    Kooij KW; Vogt L; Wit FWNM; van der Valk M; van Zoest RA; Goorhuis A; Prins M; Post FA; Reiss P;
    J Infect Dis; 2017 Sep; 216(6):622-631. PubMed ID: 28934420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study.
    Mocroft A; Lundgren JD; Ross M; Fux CA; Reiss P; Moranne O; Morlat P; Monforte Ad; Kirk O; Ryom L;
    Lancet HIV; 2016 Jan; 3(1):e23-32. PubMed ID: 26762990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) chronic kidney disease risk score in HIV-infected patients in the USA.
    Mills AM; Schulman KL; Fusco JS; Brunet L; Hsu R; Beyer A; Prajapati G; Mounzer K; Fusco GP
    HIV Med; 2020 May; 21(5):299-308. PubMed ID: 31985887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of a Polygenic Risk Score With Osteoporosis in People Living With HIV: The Swiss HIV Cohort Study.
    Schwenke JM; Thorball CW; Schoepf IC; Ryom L; Hasse B; Lamy O; Calmy A; Wandeler G; Marzolini C; Kahlert CR; Bernasconi E; Kouyos RD; Günthard HF; Ledergerber B; Fellay J; Burkhalter F; Tarr PE;
    J Infect Dis; 2023 Sep; 228(6):742-750. PubMed ID: 37225667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and risk factors of mild chronic renal failure in HIV-infected patients: influence of female gender and antiretroviral therapy.
    Cristelli MP; Trullàs JC; Cofán F; Rico N; Manzardo C; Ambrosioni J; Bedini JL; Moreno A; Diekmann F; Miro JM;
    Braz J Infect Dis; 2018; 22(3):193-201. PubMed ID: 29782827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study.
    Mocroft A; Lundgren JD; Ross M; Law M; Reiss P; Kirk O; Smith C; Wentworth D; Neuhaus J; Fux CA; Moranne O; Morlat P; Johnson MA; Ryom L; ; ; ; ;
    PLoS Med; 2015 Mar; 12(3):e1001809. PubMed ID: 25826420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of the D: A: D Chronic Kidney Disease Risk Score Model Among People Living With HIV in the Asia-Pacific.
    Han WM; Bijker R; Chandrasekaran E; Pujari S; Ng OT; Ly PS; Lee MP; Van Nguyen K; Chan YJ; Do CD; Choi JY; Chaiwarith R; Merati TP; Kiertiburanakul S; Azwa I; Khusuwan S; Zhang F; Gani YM; Tanuma J; Sangle S; Ditangco R; Yunihastuti E; Ross J; Avihingsanon A;
    J Acquir Immune Defic Syndr; 2020 Dec; 85(4):489-497. PubMed ID: 33136750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between tenofovir exposure and reduced kidney function in a cohort of HIV-positive patients: results from 10 years of follow-up.
    Laprise C; Baril JG; Dufresne S; Trottier H
    Clin Infect Dis; 2013 Feb; 56(4):567-75. PubMed ID: 23143096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of chronic kidney disease and utility of risk prediction scores in HIV-positive individuals.
    Woolnough EL; Hoy JF; Cheng AC; Walker RG; Chrysostomou A; Woolley I; Langham F; Moso MA; Weeraratne A; Trevillyan JM
    AIDS; 2018 Aug; 32(13):1829-1835. PubMed ID: 29847332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of tenofovir exposure with kidney disease risk in HIV infection.
    Scherzer R; Estrella M; Li Y; Choi AI; Deeks SG; Grunfeld C; Shlipak MG
    AIDS; 2012 Apr; 26(7):867-75. PubMed ID: 22313955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal function and incidence of chronic kidney disease in HIV patients: a Danish cohort study.
    Rasch MG; Engsig FN; Feldt-Rasmussen B; Kirk O; Kronborg G; Pedersen C; Gerstoft J; Obel N
    Scand J Infect Dis; 2012 Sep; 44(9):689-96. PubMed ID: 22680981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic kidney disease and HIV in the era of antiretroviral treatment: findings from a 10-year cohort study in a west African setting.
    Kaboré NF; Poda A; Zoungrana J; Da O; Ciaffi L; Semdé A; Yaméogo I; Sawadogo AB; Delaporte E; Meda N; Limou S; Cournil A
    BMC Nephrol; 2019 May; 20(1):155. PubMed ID: 31064340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic Kidney Disease and Antiretroviral Therapy in HIV-Positive Individuals: Recent Developments.
    Achhra AC; Nugent M; Mocroft A; Ryom L; Wyatt CM
    Curr HIV/AIDS Rep; 2016 Jun; 13(3):149-57. PubMed ID: 27130284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Administration of tenofovir disoproxil fumarate-based antiretroviral therapy in an HIV-infected patient following unilateral nephrectomy.
    Biagi M; Badowski M; Chiampas T; Young J; Vaughn P; Shicker L; Patel M
    Int J STD AIDS; 2016 Aug; 27(9):808-11. PubMed ID: 26378193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The significance of antiretroviral-associated acute kidney injury in a cohort of ambulatory human immunodeficiency virus-infected patients.
    Wikman P; Safont P; Del Palacio M; Moreno A; Moreno S; Casado JL
    Nephrol Dial Transplant; 2013 Aug; 28(8):2073-81. PubMed ID: 23739150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors of renal impairment in HIV-infected patients on antiretroviral therapy: Results from the VACH longitudinal cohort study.
    Domingo P; Suarez-Lozano I; Gutierrez F; Estrada V; Knobel H; Palacios R; Antela A; Blanco JR; Fulladosa X;
    Nefrologia (Engl Ed); 2019; 39(5):497-505. PubMed ID: 31027896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kidney dysfunction associated with tenofovir exposure in human immunodeficiency virus-1-infected Taiwanese patients.
    Huang YS; Chan CK; Tsai MS; Lee KY; Lin SW; Chang SY; Hung CC; Chang SC
    J Microbiol Immunol Infect; 2017 Oct; 50(5):595-603. PubMed ID: 26514942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.